The end of the big pharma conglomerate

From now on it’s focus, focus, focus

The pharmaceutical industry and the make-up of its lead players continues to evolve. The current trend is a clear drive towards more focused approach:

• Focus on the prescription pharmaceutical business
• Focus on innovative product
• Focus on few targeted therapeutic areas

This paper examines the industry’s shifting landscape. We look at how key players have evolved their strategies over the past few years and offer predictions for what kind of deal activity to expect in 2022. Below is an excerpt of the report.